Monthly Archives: March 2008

Two new biotechnology books:
I’m proud to announce two new books featuring international best practices in biotechnology business development and biotechnology education. These new books respectively empower industry leaders operating in the dynamic biotechnology industry, and help address the global shortage of skilled biotechnology workers.


First Edition, March 2008
Perfect Bound, 342 pages, US$74.95
ISBN: 978-09734676-7-3
Best Practices in Biotechnology Education
22 International Best Practices in K-12, College, Certificate, Master’s, Doctoral, MBA, Distance Education Programs and Student Groups
This international compilation is directed at faculty and program directors seeking to start or expand biotechnology education programs; policy makers and economic developers seeking to meet workforce needs; and, students, scientists, and business professionals looking to enter the biotechnology industry or upgrade their existing skills. The included cases describe a wide variety of international programs from high-school through Ph.D. levels, and student clubs. Some programs are in their first years whereas others are quite mature and have diversified to offer myriad degree and certificate programs.

First Edition, March 2008
Perfect Bound, 186 pages, US$67.95
ISBN: 978-09734676-0-4
Best Practices in Biotechnology Business Development
Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
Best Practices in Biotechnology Business Development provides a framework to understand critical issues in biotechnology business development. Experts from a wide range of disciplines have contributed best practices based on their experiences and expertise, enabling biotechnology entrepreneurs, senior managers, directors, and officers to develop a better understanding of the key elements in these operations, empowering them to better manage their implementation.
These books complement my recent title, Building Biotechnology:

Second Edition, August 2006
Hardcover, 320 pages, US$54.95
ISBN: 09734676-3-0
Building Biotechnology
Scientists know science; businesspeople know business.
This book explains both.

As biotechnology changes paradigms in medicine, agriculture, and industrial processes, there is a pressing need for cross-trained individuals capable of developing new innovations and bringing them to market. Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

For more information, contact

Courtesy of

Drug Patent Expirations in March 2008
*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
CARDIZEM CD Biovail diltiazem hydrochloride 5,002,776 MAR 26,2008
CARDURA XL Pfizer doxazosin mesylate 4,837,111 MAR 21,2008
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER Bayer Pharms ciprofloxacin 4,957,922 MAR 18,2008
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Bayer Pharms ciprofloxacin 4,957,922 MAR 18,2008
ESCLIM Women First Hlthcare estradiol 4,842,864 MAR 25,2008
IFEX Bristol Myers Squibb ifosfamide 4,882,452 MAR 03,2008
IFEX/MESNEX KIT Bristol Myers Squibb ifosfamide; mesna 4,882,452 MAR 03,2008
NEXIUM Astrazeneca esomeprazole magnesium 4,738,974 MAR 01,2008
NEXIUM Astrazeneca esomeprazole magnesium 4,783,974 MAR 01,2008
RESCULA R Tech Ueno Ltd unoprostone isopropyl 5,151,444 MAR 19,2008
SEMPREX-D Ucb Inc acrivastine; pseudoephedrine hydrochloride 4,650,807 MAR 26,2008
TOPROL-XL Astrazeneca metoprolol succinate 4,957,745 MARVariationen von <a href=”” mce_href=””>strip poker download</a>. 18,2008
TOPROL-XL Astrazeneca metoprolol succinate 5,001,161 MAR 18,2008
TOPROL-XL Astrazeneca metoprolol succinate 5,081,154 MAR 18,2008
UVADEX Therakos methoxsalen 4,999,375 MAR 12,2008
VIVELLE Novartis estradiol 4,814,168 MAR 04,2008
VIVELLE Novartis estradiol 4,994,267 MAR 04,2008
VIVELLE Novartis estradiol 4,994,278 MAR 04,2008
VUSION Barrier miconazole nitrate; petrolatum, white; zinc oxide 4,911,932 MAR 27,2008

Courtesy of